Q2 2020 Holdings
Filed 2020-08-14 | 14 holdings | $32.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $24.3M | 563,291 | 74.0% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $8.1M | 35,800 | 24.5% |
| Spdr SER TR S&P Biotech(XBI)Put | UNIT | 78464A870 | $223.9K | 2,000,000 | 0.7% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $36.9K | 1,454,686 | 0.1% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $35.5K | 1,590,733 | 0.1% |
| Uniqure NV(QURE) | SHS | N90064101 | $30.6K | 679,620 | 0.1% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $26.3K | 1,943,081 | 0.1% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $24.6K | 315,029 | 0.1% |
| NGM Biopharmaceuticals Inc(NGMUSD) | COM | 62921N105 | $21.6K | 1,095,184 | 0.1% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $20.4K | 553,453 | 0.1% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $17.3K | 5,575,530 | 0.1% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $14.6K | 2,401,570 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $8.7K | 44,234 | 0.0% |
| Morphosys AG | SPONSORED ADS | 617760202 | $3.0K | 95,898 | 0.0% |